Metoprolol Tartrate Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets(IR & ER)
Available Strengths: IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg
Reference Brands: US: Lopressor(IR); Toprol-XL(ER)
Category:
Heart Disorder
Metoprolol is a selective beta-1 blocker that reduces heart rate, blood pressure, and cardiac output by inhibiting adrenaline effects on the heart. It effectively manages hypertension, angina, and heart failure. Benefits include decreased cardiovascular workload, reduced risk of heart attack, improved heart rhythm, and overall cardiovascular health.
Metoprolol Tartrate tablet is available in Tablets(IR & ER)
and strengths such as IR: 25 mg, 50 mg, 100 mg; ER: 25 mg, 50 mg, 100 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metoprolol Tartrate tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metoprolol Tartrate tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metoprolol tablets, marketed as Lopressor and Toprol-XL, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and heart failure management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial data and manufacturing quality for timely approval, while the EMA ensures compliance with regional safety and quality standards. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper adherence supports rapid approval, safe use, and worldwide availability, helping improve cardiovascular health outcomes globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing